By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.




CEO: John F. Milligan, PhD

Chief Scientific Officer: Norbert W. Bischofberger, PhD

CFO: Robin L. Washington

COO: Kevin Young


Please click here for clinical trial information.

Key Statistics

Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD

Company News
Gilead (GILD) Submits New Drug Application To The FDA For The Investigational Single Tablet Regimen Sofosbuvir/Velpatasvir/Voxilaprevir 12/8/2016 10:48:13 AM
Gilead (GILD) CEO Remorseful Over Sovaldi's $1,000 Per Pill Price Tag 12/8/2016 6:38:41 AM
Gilead (GILD)'s 3 Biggest Goofs of 2016 12/7/2016 5:43:44 AM
Pfizer (PFE), Gilead (GILD) and Incoming Eli Lilly (LLY) CEO Discuss Why People Don't Like or Trust Pharma Companies 12/2/2016 7:02:24 AM
A Look at Gilead (GILD) and Its Potential $10 Billion Blunder 12/2/2016 6:13:08 AM
When Will Gilead (GILD)'s Unlucky Streak End? 11/23/2016 7:14:58 AM
Reeling From GlobeImmune (GBIM) Hepatitis B Termination, Gilead (GILD) Faces Merck & Co. (MRK), GlaxoSmithKline (GSK) Competition 11/22/2016 6:09:37 AM
Does Gilead (GILD) Pass Warren Buffett's Test? 11/18/2016 7:19:58 AM
Gilead (GILD)'s R&D Woes Could Make it an Attractive Target for Allergan (AGN) and Pfizer (PFE) 11/18/2016 5:30:29 AM
Embattled GlobeImmune (GBIM) Loses Gilead (GILD) Deal, Cancels HQ Lease, and CEO Resigns 11/17/2016 4:35:19 PM